Brind.

Medtronic's TAVR systems were found to infringe on Colibri's patented method, but the ruling was overturned by the US Court of Appeals.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Medtronic's TAVR systems were found to infringe on Colibri's patented method, but the ruling was overturned by the US Court of Appeals.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Medical Device NetworkMedtronic’s $106m heart valve patent infringement ruling overturned The US Court of Appeals has overturned a $106.5m ruling wherein a California court jury found that Medtronic infringed on a heart v